Tag: Aclipse Therapeutics

Radnor Firm Aclipse Therapeutics Receives Australian Grant to Develop ALS Therapy

A Radnor biopharmaceutical company has been awarded $720,000 to fund an experimental therapy being developed there for amyotrophic lateral sclerosis (ALS), writes John George…